Synapse - Dual-targeted therapy with ruxolitinib plus duvelisib for T-cell lymphoma

Dual-targeted therapy with ruxolitinib plus duvelisib for T-cell lymphoma Meeting Abstract

Authors:	Moskowitz, A.; Ganesan, N.; Chang, T.; Davey, T.; Hancock, H.; Smith, M.; Assini, A.; Sarmasti, L.; Miller, T.; Gibaldi, A.; Schatz, J. H.; Jacobsen, E. D.; Geller, S.; Myskowski, P.; Kumar, A.; Lue, J. K.; Falchi, L.; Stuver, R.; Ghione, P.; Epstein-Peterson, Z. D.; Johnson, W. T.; Argyropoulos, K.; Lopez, K.; Hannigan, K.; Thet, W. S.; Ksanznak, K.; Patel, S.; Salas, M.; Subzwari, S.; Jihad, M.; Casper, E.; Galasso, N.; Schoder, H.; Dogan, A.; Vardhana, S. A.; Horwitz, S.
Abstract Title:	Dual-targeted therapy with ruxolitinib plus duvelisib for T-cell lymphoma
Meeting Title:	66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	144
Issue:	Suppl. 1
Meeting Dates:	2024 Dec 7-10
Meeting Location:	San Diego, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2024-11-05
Start Page:	463
End Page:	464
Language:	English
ACCESSION:	WOS:001415654100013
DOI:	10.1182/blood-2024-206462
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos